• About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • Clinical Trials for MS
      • PLATYPUS
      • STOP-MS
      • FIRMS-EBV
      • Other MS Clinical Trials
    • COVID-19 and MS
    • Crisis Toolkit
    • Employment
    • Family, friends and other carers
    • Health and Wellbeing
    • MS Clinics
    • NMOSD and MOGAD
    • Participate in MS Research
    • Support and Services
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • Australian MS Clinical Trials Platform
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • Proteomics of MS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • Kiss Goodbye to MS
      • The International MS Genetics Consortium
      • MS Brain Health
      • MS International Federation (MSIF)
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Aged Care
    • Alliances
    • Budgets and Elections
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • NDIS
    • NDIS Pricing
    • MS Nurses
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • Donate
    • Corporate involvement
    • Events
    • MS Australia Awards 2025
    • Participate in MS research
    • Volunteers
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • Clinical Trials for MS
      • PLATYPUS
      • STOP-MS
      • FIRMS-EBV
      • Other MS Clinical Trials
    • COVID-19 and MS
    • Crisis Toolkit
    • Employment
    • Family, friends and other carers
    • Health and Wellbeing
    • MS Clinics
    • NMOSD and MOGAD
    • Participate in MS Research
    • Support and Services
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • Australian MS Clinical Trials Platform
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • Proteomics of MS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • Kiss Goodbye to MS
      • The International MS Genetics Consortium
      • MS Brain Health
      • MS International Federation (MSIF)
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Aged Care
    • Alliances
    • Budgets and Elections
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • NDIS
    • NDIS Pricing
    • MS Nurses
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • Donate
    • Corporate involvement
    • Events
    • MS Australia Awards 2025
    • Participate in MS research
    • Volunteers
NEWS
RESOURCES
PODCAST
  • NEWS
  • RESOURCES
  • PODCAST
  • VIDEOS
  • CONTACT
Donate
Subscribe
Search
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • Clinical Trials for MS
      • PLATYPUS
      • STOP-MS
      • FIRMS-EBV
      • Other MS Clinical Trials
    • COVID-19 and MS
    • Crisis Toolkit
    • Employment
    • Family, friends and other carers
    • Health and Wellbeing
    • MS Clinics
    • NMOSD and MOGAD
    • Participate in MS Research
    • Support and Services
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • Australian MS Clinical Trials Platform
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • Proteomics of MS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • Kiss Goodbye to MS
      • The International MS Genetics Consortium
      • MS Brain Health
      • MS International Federation (MSIF)
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Aged Care
    • Alliances
    • Budgets and Elections
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • NDIS
    • NDIS Pricing
    • MS Nurses
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • Donate
    • Corporate involvement
    • Events
    • MS Australia Awards 2025
    • Participate in MS research
    • Volunteers
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • Clinical Trials for MS
      • PLATYPUS
      • STOP-MS
      • FIRMS-EBV
      • Other MS Clinical Trials
    • COVID-19 and MS
    • Crisis Toolkit
    • Employment
    • Family, friends and other carers
    • Health and Wellbeing
    • MS Clinics
    • NMOSD and MOGAD
    • Participate in MS Research
    • Support and Services
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • Australian MS Clinical Trials Platform
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • Proteomics of MS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • Kiss Goodbye to MS
      • The International MS Genetics Consortium
      • MS Brain Health
      • MS International Federation (MSIF)
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Aged Care
    • Alliances
    • Budgets and Elections
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • NDIS
    • NDIS Pricing
    • MS Nurses
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • Donate
    • Corporate involvement
    • Events
    • MS Australia Awards 2025
    • Participate in MS research
    • Volunteers
Injectable Ocrevus® (ocrelizumab) listed on the PBS 4 December 2025
MS News MS Trials
Injectable Ocrevus® (ocrelizumab) listed on the PBS
Helping healthcare providers support people with MS through exercise 26 November 2025
MS News MS Trials
Helping healthcare providers support people with MS through exercise
Promising early results for a new BTK inhibitor for progressive MS 26 November 2025
MS News MS Trials
Promising early results for a new BTK inhibitor for progressive MS
Over 9,500 experts meet in Barcelona to shape the future of MS care and research 29 October 2025
MS Brainbank MS News MS Trials
Over 9,500 experts meet in Barcelona to shape the future of MS care and research
Optimising MS care in older people 29 October 2025
MS Brainbank MS News MS Trials
Optimising MS care in older people
Menopause does not worsen disability in MS 29 October 2025
MS Brainbank MS News MS Trials
Menopause does not worsen disability in MS
New study shows COVID-19 boosters strengthen protection in MS, even with immune-suppressing treatments 26 August 2025
MS News MS Trials
New study shows COVID-19 boosters strengthen protection in MS, even with immune-suppressing treatments
Early identification of MS risk using EBV antibodies 29 July 2025
MS Brainbank MS News MS Trials
Early identification of MS risk using EBV antibodies
MS and EBV: Two clinical trials launch in Australia 24 June 2025
MS News MS Trials
MS and EBV: Two clinical trials launch in Australia
Our nurses, our future: Caring for MS nurses 24 June 2025
MS News MS Trials
Our nurses, our future: Caring for MS nurses
Load More
MS Australia
registered charity

1300 010 158

info@msaustralia.org.au

Head Office

Suite 3.01, 18 Flour Mill Way
Summer Hill NSW 2130

Participate in MS Research

  • MS Clinical Trials
  • MS Australia Brain Bank
  • Australian MS Longitudinal Study
Facebook-f X-twitter Linkedin-in Youtube Instagram Spotify Paper-plane

Quick links

  • What is MS?
  • How is MS diagnosed?
  • COVID-19 and MS
  • Research funding opportunities
  • Research we fund
  • Media enquiries
  • Contact us
© 2025 Multiple Sclerosis Australia | ABN: 51 008 515 508 │Privacy Policy | Whistleblower Policy | Complaints Policy | Terms and Conditions
© 2024 Multiple Sclerosis Australia
ABN: 51 008 515 508
Privacy Policy | Whistleblower Policy
Complaints Policy | Terms and Conditions
SUBSCRIBE
DONATE
CONTACT

Newsletter subscription

  • This field is for validation purposes and should be left unchanged.

Injectable Ocrevus® (ocrelizumab) listed on the PBS